30 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
incident that has resulted in any loss, unauthorized access, use, disclosure or modification of any such trade secrets.
(o)Except as set forth … , corruption, destruction, or other misuse of any information subject to Data Protection Laws (including any ransomware incident) that Borrower or any
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
agrees to pay, without right of reimbursement from the other, all costs and expenses incurred by it incident to the performance of its obligations
8-K
EX-1.1
fh65cmcvina1fevt
18 May 23
Other Events
5:02pm
8-K
EX-10.1
2uegwwad
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am
8-K
EX-3.1
n94l7
18 Nov 20
Departure of Directors or Certain Officers
4:06pm